News About: Pharm. Industry
Hanmi grew 33.4 percent in September
The value by Hanmi Pharm in the outpatient prescription sector in September grew 33.4 percent, to 18.7 billion won, compared with the same month of last year, due to strong demand of its first generic version of Norva...
Substantial changes foreseen in anti-hypertension drug markets.
Daewoong may introduce Olmetec, a new anti-hypertension drug, an angiotensin II receptor blocker, next year after its health registration completing in Oct. this year, which seems to cause a big change in the anti-hyp...
Amlodipine generics to curb monopoly growth of Norvasc.
The market shares of the Norvasc (anti-hypertension drug) and Amaryl (anti-diabetic drug) generic drugs grew up in a remarkable stance after the recent massive market entries.
A market survey conducted by UB Care ...
Pfizer Korea sponsors symposia on Detrusitol SR
Pfizer Korea said it has sponsored its launching symposium concerning Detrusitol (L-tolterodine tartrate) SR using a double-capsule DDS formulation, which is used to relieve urinary difficulties, including frequent ur...
SK pledged to be a global enterprise.
In the company workshop at the Telecommunication Public Servant Education Center located in Cheonan. Choongnam province from Oct. 6 to 7, President Shin Seung-kwon of SK Pharm. Co. declared the company vision ensuring...
Domestic erythropoietin market contested by 3 pharmaceutical firms
Business sources says that the domestic erythropoietin (EPO) market has emerged as an arena of tripartite competition CJ Corporation's Epokine, Choong-wae Pharm's Recormon (Roche licensing-in) and Daiichi-Kirin's Ara...
Competitors turn eyes to domestic anti-migraine market
Riding on a tidal wave of better public awareness on migraine, a number of new players are poised to enter the domestic market for gaining a bigger share, albeit its smaller annual market size valued at 7.0 billion wo...
Cialis wins 2004 Asian Brand Marketing Effectiveness Awards
Korea's public relations campaign for CIALIS (tadalafil), which has been shown to improve erectile function in most men, received a gold PR prize (Most Effective Use of Public Relations) in the 2004 Asian Brand Market...
Key products of foreign corporations on hot competition.
Most of foreign multinational drug corporations in Korea have enjoyed their business almost exclusively with their key R&D innovative products. However, recently these key products encountered a harsh competition and ...
Abbott Korea launches tulobuterol patch
Abbott Korea said it has launched tulobuterol patch (brandname: Hokunalin) for the treatment of asthma.
Tulobuterol patch, which was developed to address nocturnal symptoms and maintenance of lung function in asthm...
Which are outstanding tetravalent vaccines even for the young?
Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer
Who will be the next Pharmaceutical Safety Bureau Director?
Celltrion completes clinical trials for Remsima SC for European approval
Sales listed pharmas made in the first half of the year
April
January
February
March
April
May
June
July
August
September
October
November
December
2025
1950
1951
1952
1953
1954
1955
1956
1957
1958
1959
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
2045
2046
2047
2048
2049
2050
| Sun | Mon | Tue | Wed | Thu | Fri | Sat |
|---|---|---|---|---|---|---|
30 | 31 | 1 | 2 | 3 | 4 | 5 |
6 | 7 | 8 | 9 | 10 | 11 | 12 |
13 | 14 | 15 | 16 | 17 | 18 | 19 |
20 | 21 | 22 | 23 | 24 | 25 | 26 |
27 | 28 | 29 | 30 | 1 | 2 | 3 |
00:00
01:00
02:00
03:00
04:00
05:00
06:00
07:00
08:00
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
18:00
19:00
20:00
21:00
22:00
23:00
